SCHEMBL3936320

SCHEMBL3936320

CCC(O)C1CCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3937383 0.88 CPN1 (0.46)
SCHEMBL28892 0.86 CPN1 (0.39)
SCHEMBL24073205 0.83 KCNH2 (0.35)
SCHEMBL13153397 0.83 KCNH2 (0.35)
SCHEMBL3924943 0.81
SCHEMBL6488553 0.80
SCHEMBL6488556 0.80
SCHEMBL3719695 0.78
Hydrochloric Acid SCHEMBL28345867 0.78 SLC6A2 (0.36)
SCHEMBL22264537 0.77 KCNH2 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115243789-A Catalyst composition for polyurethane 迈图高新材料公司 2022-10-25 CN disclosed
EP-3442977-A1 INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE Blueprint Medicines Corporation (US) 2019-02-20 EP disclosed
WO-2017181117-A1 INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE BLUEPRINT MEDICINES CORPORATION (US) 2017-10-19 WO disclosed
CN-102471369-A Peptidic compound and use of same UNIV KEIO 2012-05-23 CN disclosed
WO-2009007390-A2 2-PYRAZ INYLBENZ IMIDAZOLE DERIVATIVES AS RECEPTOR TYROSINE KINASE INHIBITORS ASTRAZENECA AB (SE) 2009-01-15 WO disclosed